Product NDC: | 0062-2085 |
Proprietary Name: | Axert |
Non Proprietary Name: | almotriptan malate |
Active Ingredient(s): | 12.5 mg/1 & nbsp; almotriptan malate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0062-2085 |
Labeler Name: | Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021001 |
Marketing Category: | NDA |
Start Marketing Date: | 20010507 |
Package NDC: | 0062-2085-02 |
Package Description: | 2 TABLET, COATED in 1 BLISTER PACK (0062-2085-02) |
NDC Code | 0062-2085-02 |
Proprietary Name | Axert |
Package Description | 2 TABLET, COATED in 1 BLISTER PACK (0062-2085-02) |
Product NDC | 0062-2085 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | almotriptan malate |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20010507 |
Marketing Category Name | NDA |
Labeler Name | Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
Substance Name | ALMOTRIPTAN MALATE |
Strength Number | 12.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |